Sais e Derivados de API
Os sais dos Ingredientes Farmacêuticos Ativos (API) são compostos formados pela reação de um ácido com uma base, resultando em um equilíbrio iônico. Esses sais frequentemente melhoram a solubilidade e a estabilidade dos APIs, facilitando sua absorção no organismo. Os derivados de API são variantes químicas de um princípio ativo que podem apresentar propriedades aprimoradas ou modificadas para otimizar a eficácia terapêutica. Os sais de APIs são utilizados na formulação de medicamentos orais, injetáveis e tópicos. Além disso, os derivados de API podem melhorar a farmacocinética dos fármacos, permitindo, por exemplo, a liberação controlada de substâncias ativas.
Na CymitQuimica, oferecemos sais e derivados de APIs com a pureza e qualidade necessárias para pesquisa e desenvolvimento de formulações farmacêuticas.
Foram encontrados 79473 produtos de "Sais e Derivados de API"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Moxifloxacin Related Compound G (1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid, monohydrochloride)
CAS:Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticidesFórmula:C21H24FN3O4·HClCor e Forma:Yellow PowderPeso molecular:437.15176Methotrexate Related Compound C ((S)-2-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl](methyl)amino}benzamido) pentanedioic acid)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C20H21N7O6Cor e Forma:Dark Yellow Orange PowderPeso molecular:455.42Ticagrelor Related Compound B
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C23H28F2N6O4SCor e Forma:White Off-White Crystalline PowderPeso molecular:522.18608Repaglinide Related Compound B (3-Ethoxy-4-ethoxycarbonylphenylacetic acid)
CAS:Carboxylic acids with additional oxygen function and thFórmula:C13H16O5Cor e Forma:PowderPeso molecular:252.09977Escitalopram Related Compound A ((S)-4-[4-dimethylamino-1-(4-fluoropheny)-1-hydroxy-1-butyl]-3-hydroxymethylbenzonitrile hemi(+)-di-toluoyltartrate)
CAS:Nitrile function compounds, not elsewhere specified orFórmula:C20H23FN2O2C20H18O8Cor e Forma:PowderPeso molecular:342.17436Amoxapine Related Compound D (2-Chlorodibenzo[b,f]-[1,4]-oxazepin-11-one)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C13H8ClNO2Cor e Forma:Yellow PowderPeso molecular:245.02436Chlorothiophene Aldehyde (5-chlorothiophene-2-carbaldehyde)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C5H3ClOSCor e Forma:Brown LiquidPeso molecular:146.59 g/molTestosterone Related Compound I (17β-Hydroxyandrosta-4,6-dien-3-one)
CAS:Adrenal cortical hormones and their derivatives nesoiFórmula:C19H26O2Cor e Forma:Yellow Powder NeedlesPeso molecular:286.19328Cyclosporine Resolution Mixture (This material is an approximate 100:1 (w/w) mixture of cyclosporine and cyclosporine U)
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCor e Forma:White PowderIndomethacin Related Compound A (2-(5-methoxy-2-methyl-1H-indol-3-yl)acetic acid)
CAS:Aromatic or modified aromatic drugs with nitrogen heteroFórmula:C12H13NO3Cor e Forma:Light Yellow Crystalline PowderPeso molecular:219.08954Memantine Related Compound G (3-Methyladamantan-1-amine hydrochloride)
CAS:Cyclanic, cyclenic or cycloterpenic mono- or polyamines, and their derivatives; salts thereofFórmula:C11H19N·HClCor e Forma:White PowderPeso molecular:201.7Doxazosin Related Compound D (1,4-benzodioxane-2-carboxylic acid)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFórmula:C9H8O4Cor e Forma:Off-White Crystalline PowderPeso molecular:180.04226Buspirone Related Compound L (8-(4-Chlorobutyl)-8-azaspiro[4.5]decane-7,9-dione)
CAS:Imides and their derivatives (excluding sacharin), salt thereofFórmula:C13H20ClNO2Cor e Forma:Colorless Clear Light Yellow LiquidPeso molecular:257.76Phenylephrine Related Compound G ((R)-N-(2-Hydroxy-2-(3-hydroxyphenyl)ethyl)-N-methylglycine)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-pheFórmula:C11H15NO4Cor e Forma:White PowderPeso molecular:225.10011Azelastine Related Compound F (4-[4-(4-Chlorobenzyl)-1-oxophthalazin-2(1H)-yl]-1-methylazepane 1-oxide)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C22H24ClN3O2Cor e Forma:White SolidPeso molecular:397.9Clopidogrel Related Compound A ((+)-(S)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid, hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C15H14ClNO2S·HClCor e Forma:Off-White PowderPeso molecular:307.04338Diphthalimido Morpholinone Analog (2,2'-((2R,2'R)-((4-(3-oxomorpholino)phenyl)azanediyl)bis(2-hydroxypropane-3,1-diyl))bis(isoindoline-1,3-dione))
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C32H30N4O8Cor e Forma:Pale Yellow SolidPeso molecular:598.61Pravastatin Related Compound A (Sodium (3R,5R)-3,5-dihydroxy-7-[(1S,2R,3S,8S,8aR)-3-hydroxy-2-methyl-8-[[(2S)-2-methylbutanoyl]oxy]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] heptanoate)
CAS:Carboxylic acids w/ alcohol function but w/o other oxygen function and their derivatives, nesoiFórmula:C23H35NaO7Cor e Forma:White Off-White PowderPeso molecular:446.22805Tacrolimus Related Compound A (See USP Certificate for full Chemical Name)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C43H69NO12Cor e Forma:White Light Yellow PowderPeso molecular:792.01Benzhydrol
CAS:Aromatic alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFórmula:C13H12OCor e Forma:White Off-White PowderPeso molecular:184.08882Urea
CAS:Urea, whether or not in aqueous solutionFórmula:CH4N2OCor e Forma:White Powder CrystalsPeso molecular:60.03236Cyclizine Related Compound A (1-Methylpiperazine)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C5H12N2Cor e Forma:Colorless Clear Pale Yellow LiquidPeso molecular:100.10005Methoxsalen Related Compound B (4,9-Dimethoxy-7H-furo[3,2-g]chromen-7-one)
CAS:Aromatic lactones used as drugsFórmula:C13H10O5Cor e Forma:PowderPeso molecular:246.05282Trimipramine Related Compound A (3-(5H-Dibenzo[b,f]azepin-5-yl)-N,N,2-trimethylpropan-1-amine)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C20H24N2Cor e Forma:Pale Yellow SolidPeso molecular:292.19395Triethylamine
CAS:Acyclic monoamines and their derivatives, nesoiFórmula:C6H15NCor e Forma:Clear Colorless LiquidPeso molecular:101.12045Clonazepam Related Compound A (3-Amino-4-(2-chlorophenyl)-6-nitrocarbostyril)
CAS:Lactams not elsewhere specified or includedFórmula:C15H10ClN3O3Cor e Forma:Yellow-Orange PowderPeso molecular:315.72Levalbuterol Related Compound E (4-(2-(tert-Butylamino)-1-hydroxyethyl)-2-(ethoxymethyl)phenol)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFórmula:C15H25N03Cor e Forma:White SolidPeso molecular:247.20485o-Flutamide
Aromatic cyclic amides (including cyclic carbamates) anFórmula:C11H11F3N2O3Cor e Forma:PowderPeso molecular:276.22Mesna Related Compound B (2,2'-Disulfanediylbis(ethane-1-sulfonic acid), dipotassium salt, crystal adduct with sodium chloride)
Organo-sulfur compounds, nesoiFórmula:C4H8K2O6S4·NaClCor e Forma:White PowderPeso molecular:415.80641Bendamustine Related Compound A (4-{5-[Bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid hydrochloride)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C16H23N3O4HClCor e Forma:White SolidPeso molecular:357.83Prednicarbate Related Compound A (1,2-Dihydroprednicarbate)
CAS:Adrenal cortical hormones and their derivatives nesoiFórmula:C27H38O8Cor e Forma:White PowderPeso molecular:490.25667Rivaroxaban
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C19H18ClN3O5SCor e Forma:White PowderPeso molecular:435.06557Clindamycin 2,3-Dipalmitate (Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-α-D-galacto-octopyranoside 2,3-dipalmitate monohydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C50H93ClN2O7S·HClCor e Forma:White Off-White SolidPeso molecular:936.61588Methylphenidate Hydrochloride Erythro Isomer Solution
CAS:Produto ControladoCompounds containing an unfused pyridine ring in the structure, nesoiFórmula:C14H19NO2·HClCor e Forma:Clear LiquidPeso molecular:269.11826Desbenzyl Donepezil Hydrochloride
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C17H23NO3·HClCor e Forma:Yellow Off-White PowderPeso molecular:325.83 g/molRisedronate Related Compound C ([2-(3-pyridinyl)ethylidene-1,1]bis(phosphonic acid))
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C7H11NO6P2Cor e Forma:White Crystalline PowderPeso molecular:267.11Clonidine Related Compound B (2-[(E)-2,6-dichlorophenylimino]-1-(1-{2-[(E)-2,6-dichlorophenylimino]-imidazolidin-1-yl}-ethyl)-imidazolidine)
CAS:Compounds containing an unfused imidazole ring (whetherFórmula:C20H20Cl4N6Cor e Forma:White Off-White PowderPeso molecular:486.23Lorazepam Related Compound B (2-Amino-2',5-dichlorobenzophenone)
CAS:Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFórmula:C13H9Cl2NOCor e Forma:Yellow Crystalline PowderPeso molecular:265.00612Rivastigmine Related Compound E ((S)-1-(3-{[Ethyl(methyl)carbamoyl]oxy}phenyl)-N,N,N-trimethylethanaminium chloride)
Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C15H25ClN2O2Cor e Forma:White SolidPeso molecular:300.16046Molindone Related Compound A (3-Ethyl-2-methyl-1,5,6,7-tetrahydro-4H-indol-4-one)
CAS:Heterocyclic compounds (excluding aromatic or modified aromatic) withnitrogen hetero-atom(s) only nesoiFórmula:C11H15NOCor e Forma:Off-White PowderPeso molecular:177.25 g/molIsoguaifenesin
CAS:Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFórmula:C10H14O4Cor e Forma:Off-White PowderPeso molecular:198.08921Rivaroxaban Ethylamino Analog (1-amino-3-((4-(3-oxomorpholino)phenyl)amino)propan-2-yl 5-chlorothiophene-2-carboxylate, hydrochloride)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C18H20ClN3O4S·2HClCor e Forma:White Off-White SolidPeso molecular:409.0863Oxybutynin Related Compound B (Cyclohexyl Mandelic Acid Methyl Ester)
CAS:Carboxylic acids w/ alcohol function but w/o other oxygen function and their derivatives, nesoiFórmula:C15H20O3Cor e Forma:White Pale Yellow PowderPeso molecular:248.14124Memantine Related Compound D (1-Bromo-3,5-dimethyladamantane)
CAS:Other halogenated derivatives of cyclanic, cyclenic or cycloterpenic hydrocarbons, excluding hexachlorocyclohexaneFórmula:C12H19BrCor e Forma:Yellow LiquidPeso molecular:242.06701Formoterol Related Compound D (N-(2-Hydroxy-5-(1-hydroxy-2-{[1-(4-methoxyphenyl)propan-2-yl](methyl)amino}ethyl)phenyl)formamide fumarate)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:(C20H26N2O4)2·C4H4O4Cor e Forma:Off-White Light Brown SolidPeso molecular:832.38947Metaxalone Related Compound A (4-((3,5-dimethylphenoxy)methyl)imidazolidin-2-one)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C12H16N2O2Cor e Forma:PowderPeso molecular:220.27Nebivolol Related Compound A (See USP Certificate for full Chemical Name)
Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFórmula:C22H25F2NO4·HClCor e Forma:PowderPeso molecular:441.9Paliperidone Related Compound C (3-(2-Chloroethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C11H15ClN2O2Cor e Forma:Off-White Crystalline PowderPeso molecular:242.08221Bisacodyl Related Compound A (4,4'-(Pyridin-2-ylmethylene)diphenol)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C18H15NO2Cor e Forma:White Crystalline PowderPeso molecular:277.11028Famotidine Related Compound B (3,5-Bis[2-[[2-[(diaminomethylene)amino]thiazol-4-yl]methylthio]ethyl]-4H-1,2,4,6-thiatriazine 1,1-dioxide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C16H23N11O2S5Cor e Forma:Yellow White PowderPeso molecular:561.73Flunixin Related Compound A (2-Chloronicotinic acid)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C6H4ClNO2Cor e Forma:Cream PowderPeso molecular:156.99306Naphazoline Related Compound A (N-(2-Aminoethyl)-2-(naphthalen-1-yl)acetamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C14H16N2OCor e Forma:Off-White Yellow SolidPeso molecular:228.12626Moxifloxacin Related Compound F (1-Cyclopropyl-6-fluoro-8-methoxy-7-(1-methyloctahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid)
CAS:Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticidesFórmula:C22H26FN3O4Cor e Forma:Off-White Yellow Tan PowderPeso molecular:415.46Rivaroxaban Open Ring S-isomer ((S)-5-chloro-N-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)thiophene-2-carboxamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C18H20ClN3O4SCor e Forma:White Off-White SolidPeso molecular:409.0863Famotidine Related Compound F (3-[[2-(diaminomethyleneamino)thiazol-4-yl]methylthio]propanoic acid)
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFórmula:C8H12N4O2S2Cor e Forma:White PowderPeso molecular:260.34Travoprost
CAS:Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analoguesFórmula:C26H35F3O6Cor e Forma:Colorless Clear Pale Yellow LiquidPeso molecular:500.23857Epinastine Related Compound A ((6,11-Dihydro-5H-dibenzo[b,e]azepin-6-yl)methanamine fumarate)
CAS:AntihistaminesFórmula:C15H16N2·C4H4O4Cor e Forma:Off-White Brown Crystalline PowderPeso molecular:340.14231Quetiapine Related Compound B (11-(Piperazin-1-yl)dibenzo[b,f][1,4]thiazepine dihydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C17H17N3S·2HClCor e Forma:Off-White PowderPeso molecular:295.11432Sodium Picosulfate Related Compound A (4-[(Pyridin-2-yl)(4-hydroxyphenyl)methyl]phenyl sodium sulfate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C18H14NNaO5SCor e Forma:White PowderPeso molecular:379.04904Fluorescein Related Compound C (2-(2,4-Dihydroxybenzoyl)benzoic acid)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFórmula:C14H10O5Cor e Forma:Off-White Pale Yellow PowderPeso molecular:258.235-Amino-2,4,6-triiodo-N-methylisophthalamic Acid
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C9H7I3N2O3Cor e Forma:White PowderPeso molecular:571.75908Irinotecan Related Compound A ((S)-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione)
CAS:Other alkaloids,natural or reproduced by synthesis, and their salts, ethers,esters&other derivatives, nesoiFórmula:C20H16N2O5Cor e Forma:Light Yellow PowderPeso molecular:364.10592Milnacipran Related Compound A (2-(Aminomethyl)-1-phenylcyclopropane-1-carboxylic acid hydrochloride)
CAS:Aromatic amino-acids and their esters,other than thoseFórmula:C11H13NO2HClCor e Forma:Off-White White SolidPeso molecular:227.69Trihexyphenidyl Related Compound A (1-Phenyl-3-(piperidin-1-yl)propan-1-one hydrochloride)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C14H19NO·HClCor e Forma:SolidPeso molecular:253.12334Citalopram Related Compound A (1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carboxamide)
CAS:Aromatic pesticides with oxygen hetero-atom(s) only neFórmula:C20H23FN2O2Cor e Forma:Cream PowderPeso molecular:342.17436Oxazepam Related Compound A (7-Chloro-5-phenyl-4,5-dihydro-1H-benzodiazepine-2,3-dione)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C15H11ClN2O2Cor e Forma:White Off-White PowderPeso molecular:286.71Amoxicillin Related Compound F (3-(4-Hydroxyphenyl)pyrazin-2-ol; phenylpyrazinediol)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFórmula:C10H8N2O2Cor e Forma:Yellow PowderPeso molecular:188.18Rivaroxaban Phthalimide ((S)-2-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)isoindoline-1,3-dione)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C21H21N3O5Cor e Forma:White Off-White SolidPeso molecular:395.14812Formoterol Related Compound C (N-(2-Hydroxy-5-(1-hydroxy-2-{[1-(4-methoxyphenyl)propan-2-yl]amino}ethyl)phenyl)acetamide fumarate)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:(C20H26N2O4)2·C4H4O4Cor e Forma:Off-White Light Brown SolidPeso molecular:832.95Piroxicam Related Compound A (Pyridin-2-amine)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C5H6N2Cor e Forma:Yellow SolidPeso molecular:94.0531Losartan Related Compound D (5-[4'-({2-Butyl-5-[(5-{4'-[(2-butyl-4-chloro-5-hydroxymethyl-1H-imidazol-1-yl)methyl]biphenyl-2-yl}-1H-tetrazol-1-yl)methyl]-4-chloro-1H-imidazol-1-yl}methyl)biphenyl-2-yl]tetrazol, potassium salt)
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFórmula:C44H43Cl2KN12OCor e Forma:PowderPeso molecular:864.26969Oxacillin Related Compound C (5-Methyl-3-phenylisoxazole-4-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C11H9NO3Cor e Forma:Off-White PowderPeso molecular:203.05824Celecoxib Related Compound C (4-[5-(2,4-Dimethylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide)
CAS:Sulfonamides, nesoiFórmula:C18H16F3N3O2SCor e Forma:SolidPeso molecular:395.09153Oxaliplatin Related Compound F ([SP-4-2-(1R-trans)]-(1,2-cyclohexanediamine-N,N') diiodidoplatinum(II))
CAS:Inorganic or organic compounds of precious metals, whetFórmula:C6H14N2I2PtCor e Forma:PowderPeso molecular:562.88943Lovastatin Epimer Mixture (Epilovastatin and Lovastatin 1:1 Mixture)
Lactones nesoiFórmula:C24H36O5Cor e Forma:PowderPeso molecular:404.25627Decitabine Related Compound D (Methyl 4-chlorobenzoate)
CAS:Aromatic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacid and their derivatives not elsewhere specified or includedFórmula:C8H7ClO2Cor e Forma:White Yellow PowderPeso molecular:170.01346Acyclovir Related Compound F (N-[9-[(2-Hydroxyethoxy)methyl]-6-oxo-6,9-dihydro-1H-purin-2-yl]acetamide)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C10H13N5O4Cor e Forma:White Yellow Crystalline PowderPeso molecular:267.09675Brinzolamide Related Compound A ((S)-4-(Ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e] [1,2]thiazine-6-sulfonamide 1,1-dioxide), (Brinzolamide (S)-Isomer))
CAS:Sulfonamides, nesoiFórmula:C12H21N3O5S3Cor e Forma:White Off-White PowderPeso molecular:383.06433Triclosan Related Compounds Mixture A
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCor e Forma:Colorless Clear LiquidTriamterene Related Compound C (2,4-diamino-7-hydroxy-6-phenylpteridine)
CAS:Mpds cont a pyrimidine or piperazine ring, nesoi compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the strucFórmula:C12H10N6OCor e Forma:Yellow Crystalline PowderPeso molecular:254.09161Cephalexin Related Compound F ((6R,7R)-7-[(R)-2-Amino-2-phenylacetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C16H17N3O4SCor e Forma:White Off-White PowderPeso molecular:347.09398Levofloxacin Related Compound E ((S)-9-Fluoro-2,3-dihydro-3-methyl-10-[2-(methylamino)ethylamino]-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C16H18FN3O4·HClCor e Forma:Off-White Yellow PowderPeso molecular:371.79Phthalic Acid
CAS:Aromatic polycarboxylic acids, their anhydrides, halides, peroxides, peroxyacids etc not elsewhere specified or includedFórmula:C8H6O4Cor e Forma:White PowderPeso molecular:166.13 g/molEletriptan Related Compound B ((R)-5-Bromo-3-[(1-methylpyrrolidin-2-yl)methyl]-1H-indole)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFórmula:C14H17BrN2Cor e Forma:Light Yellow PowderPeso molecular:293.2Bumetanide Related Compound A (3-Amino-4-phenoxy-5-sulfamoylbenzoic Acid)
CAS:Sulfonamides, nesoiFórmula:C13H12N2O5SCor e Forma:White Off-White PowderPeso molecular:308.31Bendamustine Related Compound G (4-[6-(2-Chloroethyl)-3,6,7,8-tetrahydro-3-methylimidazo[4,5-h][1,4]benzothiazin-2-yl]butanoic acid hydrochloride)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C16H20ClN3O2S·HClCor e Forma:Off-White Light Brown SolidPeso molecular:389.07315Iodixanol Related Compound C (5-[Acetyl[3-[[3,5-bis[[(2,3-dihydroxypropyl)amino]carbonyl]-2,4,6-triiodophenyl]amino]-2-hydroxypropyl]amino]-N,N'-bis-(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C33H42I6N6O14Cor e Forma:White Off-White PowderPeso molecular:1508.15Bumetanide Related Compound B (3-Nitro-4-phenoxy-5-sulfamoylbenzoic Acid)
CAS:Sulfonamides, nesoiFórmula:C13H10N2O7SCor e Forma:Light Yellow PowderPeso molecular:338.02087Pramipexole Related Compound F ((6S,7R)-2-Amino-6-(propylamino)-4,5,6,7-tetrahydrobenzothiazol-7-ol)
CAS:Compounds containing a benzothiazole ring-system (whether or not hydrogenated), not further fusedFórmula:C10H17N3OSCor e Forma:Off-White SolidPeso molecular:227.10923Dopamine Related Compound B (4-(2-Aminoethyl)-2-methoxyphenol hydrochloride)
CAS:Amino-naphthols and other amino-phenols, their ethers and esters, other than those cont more than one kind of oxygen function; salts thereof nesoiFórmula:C9H13NO2·HClCor e Forma:Off-White SolidPeso molecular:203.07131Flutamide Related Compound A (4-nitro-3-(trifluoromethyl)aniline)
CAS:Toluidines (aminotoluenes) and their derivatives, salts thereofFórmula:C7H5F3N2O2Cor e Forma:PowderPeso molecular:206.03031Uracil Arabinoside
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C9H12N2O6Cor e Forma:White Off-White PowderPeso molecular:244.23Metformin Related Compound B (1-Methylbiguanide hydrochloride)
CAS:Non-aromatic imines and their derivatives; salts thereof, nesoiFórmula:C3H9N5·HClCor e Forma:White PowderPeso molecular:151.63Orphenadrine Related Compound F (N,N-Dimethyl-2-[phenyl(p-tolyl)methoxy]ethanamine citrate)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFórmula:C18H23NO·C6H8O7Cor e Forma:White PowderPeso molecular:461.20497Allopurinol Related Compound D (Ethyl 5-amino-1H-pyrazole-4-carboxylate)
CAS:Compounds containing an unfused pyrazole ring (whether or not hydrogenated) in the structure nesoiFórmula:C6H9N3O2Cor e Forma:White Light Yellow Crystalline PowderPeso molecular:155.06948Formoterol Related Compound I (N-(2-hydroxy-5-[(RS)-1-hydroxy-2-{[(SR)-1-(4-methoxyphenyl)propan-2-yl]amino}ethyl]phenyl)formamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C19H24N2O4Cor e Forma:Off-White SolidPeso molecular:344.17361Ecamsule Related Compound G (4-((E)-((1SR,4SR)-7,7-dimethyl-3-oxo-4-(sulfomethyl)bicyclo[2.2.1]heptan-2-ylidene)methyl)benzaldehyde, sodium salt)
CAS:Halogenated, sulfonated, nitrated or nitrosated derivatFórmula:C18H19NaO5SCor e Forma:White PowderPeso molecular:370.4Estradiol Related Compound C (1,3,5(10)-estratrien-3,17β-diol-6-one)
CAS:Estrogens and progestinsFórmula:C18H22O3Cor e Forma:White Yellow Crystalline PowderPeso molecular:286.15689Roflumilast Related Compound E (N-(3-Bromo-5-chloropyridin-4-yl)-3-(cyclopropylmethoxy)-4-(difluoromethoxy)benzamide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C17H14BrClF2N2O3Cor e Forma:White Beige PowderPeso molecular:445.98444Benzophenone (Diphenylmethanone)
CAS:Aromatic ketones without other oxygen function, nesoiFórmula:C13H10OCor e Forma:Colorless White Crystalline Powder CrystalsPeso molecular:182.21 g/mol
![Buspirone Related Compound L (8-(4-Chlorobutyl)-8-azaspiro[4.5]decane-7,9-dione)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1078824.webp&w=3840&q=75)
![Trimipramine Related Compound A (3-(5H-Dibenzo[b,f]azepin-5-yl)-N,N,2-trimethylpropan-1-amine)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1692710.webp&w=3840&q=75)
![Risedronate Related Compound C ([2-(3-pyridinyl)ethylidene-1,1]bis(phosphonic acid))](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1604643.webp&w=3840&q=75)
![Famotidine Related Compound B (3,5-Bis[2-[[2-[(diaminomethylene)amino]thiazol-4-yl]methylthio]ethy…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1269221.webp&w=3840&q=75)
